Skip to main content

Litchev Boyan Vesselinov's Form 4 filing

Indaptus Therapeutics, Inc.INDP · filed Dec 19, 2022

Accession no.
0001493152-22-035926
Filed
Dec 19, 2022
Trade date
Jan 31-Dec 1, 2022
Filing delay
322 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions. Open-market purchases total $2.52K. It was filed 322 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Litchev Boyan VesselinovCIK 0001902726Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 31, 2022Common StockPPurchaseAcquired+100$4.65+$465100Direct
Mar 2, 2022Common StockPPurchaseAcquired+50$4.09+$204.5150Direct
Nov 22, 2022Common StockPPurchaseAcquired+500$1.83+$915650Direct
Dec 1, 2022Common StockPPurchaseAcquired+500$1.87+$9351,150Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)